Search

everythinglearnresearchcommunity

for

Search:↓

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

RCS-01 is safe and may help rejuvenate aging skin.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Electron Beam Tomography (EBT) is a useful additional test to stress testing for detecting heart disease.

The Rotterdam Study aims to understand various diseases in older adults.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Microbeam Radiation Therapy is effective, but using a linear accelerator reduces its benefits.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

RTA 408 cream protects mice from radiation skin damage.

Low-dose Ritlecitinib may help children with stubborn Alopecia Areata.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

The new protocol using Cellutome™ and RCM safely assesses wound healing in detail.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

Tsc2-deficient stem cells can help understand and treat TSC-related tumors.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Skin CT can help diagnose rosacea by identifying specific skin features, but should be used with clinical signs to avoid misdiagnosis.

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

CRET therapy affects inflammation in skin cells by changing cytokine levels and activating certain proteins.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.